
Savitha M. Rao
Examiner (ID: 144, Phone: (571)270-5315 , Office: P/1621 )
| Most Active Art Unit | 1629 |
| Art Unit(s) | 1691, 1614, 1621, 1629, 4131 |
| Total Applications | 1529 |
| Issued Applications | 874 |
| Pending Applications | 100 |
| Abandoned Applications | 583 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19195268
[patent_doc_number] => 11992486
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-28
[patent_title] => Methods of treating prostate cancer
[patent_app_type] => utility
[patent_app_number] => 17/989329
[patent_app_country] => US
[patent_app_date] => 2022-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8469
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17989329
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/989329 | Methods of treating prostate cancer | Nov 16, 2022 | Issued |
Array
(
[id] => 18683842
[patent_doc_number] => 11779551
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-10-10
[patent_title] => Antitoxins to brevetoxin
[patent_app_type] => utility
[patent_app_number] => 18/049468
[patent_app_country] => US
[patent_app_date] => 2022-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 22
[patent_no_of_words] => 10658
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18049468
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/049468 | Antitoxins to brevetoxin | Oct 24, 2022 | Issued |
Array
(
[id] => 19854409
[patent_doc_number] => 12257217
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-03-25
[patent_title] => Compositions and methods for treating hyperphagia in prader-willi syndrome
[patent_app_type] => utility
[patent_app_number] => 18/046919
[patent_app_country] => US
[patent_app_date] => 2022-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 44
[patent_no_of_words] => 17093
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18046919
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/046919 | Compositions and methods for treating hyperphagia in prader-willi syndrome | Oct 14, 2022 | Issued |
Array
(
[id] => 18626546
[patent_doc_number] => 20230285333
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => COMPOSITIONS AND METHODS FOR CONTROLLING FOOD INTAKE OF ANIMAL
[patent_app_type] => utility
[patent_app_number] => 18/046917
[patent_app_country] => US
[patent_app_date] => 2022-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16648
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18046917
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/046917 | Compositions and methods for controlling food intake of animal | Oct 14, 2022 | Issued |
Array
(
[id] => 19896787
[patent_doc_number] => 12274681
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-15
[patent_title] => Compositions and methods for reducing skin fat
[patent_app_type] => utility
[patent_app_number] => 18/046916
[patent_app_country] => US
[patent_app_date] => 2022-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 45
[patent_no_of_words] => 12294
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18046916
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/046916 | Compositions and methods for reducing skin fat | Oct 14, 2022 | Issued |
Array
(
[id] => 18336245
[patent_doc_number] => 20230128194
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => METHODS AND COMPOSITIONS TO ALTER HEPATIC GABA RELEASE TO TREAT OBESITY-RELATED CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 17/937604
[patent_app_country] => US
[patent_app_date] => 2022-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25120
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17937604
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/937604 | METHODS AND COMPOSITIONS TO ALTER HEPATIC GABA RELEASE TO TREAT OBESITY-RELATED CONDITIONS | Oct 2, 2022 | Pending |
Array
(
[id] => 18962863
[patent_doc_number] => 11896602
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-13
[patent_title] => Method for preventing pregnancy
[patent_app_type] => utility
[patent_app_number] => 17/937215
[patent_app_country] => US
[patent_app_date] => 2022-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7776
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17937215
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/937215 | Method for preventing pregnancy | Sep 29, 2022 | Issued |
Array
(
[id] => 18314113
[patent_doc_number] => 11628173
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-04-18
[patent_title] => Pharmaceutical compositions comprising meloxicam
[patent_app_type] => utility
[patent_app_number] => 17/934244
[patent_app_country] => US
[patent_app_date] => 2022-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 35
[patent_no_of_words] => 24900
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17934244
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/934244 | Pharmaceutical compositions comprising meloxicam | Sep 21, 2022 | Issued |
Array
(
[id] => 18162364
[patent_doc_number] => 20230028957
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => STABLE ORAL SUSPENSIONS OF BACLOFEN
[patent_app_type] => utility
[patent_app_number] => 17/948882
[patent_app_country] => US
[patent_app_date] => 2022-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15042
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17948882
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/948882 | Stable oral suspensions of baclofen | Sep 19, 2022 | Issued |
Array
(
[id] => 18337432
[patent_doc_number] => 20230129381
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => COMPOSITIONS AND METHODS FOR TREATMENT OF ANTICANCER-DRUG RESISTANT CANCERS
[patent_app_type] => utility
[patent_app_number] => 17/944506
[patent_app_country] => US
[patent_app_date] => 2022-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24746
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17944506
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/944506 | Compositions and methods for treatment of anticancer-drug resistant cancers | Sep 13, 2022 | Issued |
Array
(
[id] => 19854531
[patent_doc_number] => 12257342
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-03-25
[patent_title] => Phenylephrine hydrochloride ready-to-use solution
[patent_app_type] => utility
[patent_app_number] => 17/941640
[patent_app_country] => US
[patent_app_date] => 2022-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7165
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17941640
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/941640 | Phenylephrine hydrochloride ready-to-use solution | Sep 8, 2022 | Issued |
Array
(
[id] => 19209522
[patent_doc_number] => 11998557
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-04
[patent_title] => Halogenated psilocybin derivatives and methods of using
[patent_app_type] => utility
[patent_app_number] => 17/903080
[patent_app_country] => US
[patent_app_date] => 2022-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 80
[patent_no_of_words] => 38086
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17903080
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/903080 | Halogenated psilocybin derivatives and methods of using | Sep 5, 2022 | Issued |
Array
(
[id] => 18853876
[patent_doc_number] => 11851437
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-26
[patent_title] => Crystalline form of (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra-hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/901951
[patent_app_country] => US
[patent_app_date] => 2022-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 12
[patent_no_of_words] => 16268
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17901951
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/901951 | Crystalline form of (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra-hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof | Sep 1, 2022 | Issued |
Array
(
[id] => 20192202
[patent_doc_number] => 20250268912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-08-28
[patent_title] => USE OF GABAA RECEPTOR MODULATORS FOR TREATMENT OF ITCH
[patent_app_type] => utility
[patent_app_number] => 17/901356
[patent_app_country] => US
[patent_app_date] => 2022-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11829
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17901356
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/901356 | Use of GABA | Aug 31, 2022 | Issued |
Array
(
[id] => 18281600
[patent_doc_number] => 20230097072
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => UROLITHINS AS IMMUNE RESPONSE ENHANCERS
[patent_app_type] => utility
[patent_app_number] => 17/822027
[patent_app_country] => US
[patent_app_date] => 2022-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20630
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17822027
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/822027 | Urolithins as immune response enhancers | Aug 23, 2022 | Issued |
Array
(
[id] => 18198844
[patent_doc_number] => 20230052363
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING RENAL INJURY
[patent_app_type] => utility
[patent_app_number] => 17/892585
[patent_app_country] => US
[patent_app_date] => 2022-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28270
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17892585
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/892585 | COMPOSITIONS AND METHODS FOR TREATING RENAL INJURY | Aug 21, 2022 | Pending |
Array
(
[id] => 18075944
[patent_doc_number] => 20220401556
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => USE OF VDAS TO ENHANCE IMMUNOMODULATING THERAPIES AGAINST TUMORS
[patent_app_type] => utility
[patent_app_number] => 17/893105
[patent_app_country] => US
[patent_app_date] => 2022-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9406
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17893105
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/893105 | USE OF VDAS TO ENHANCE IMMUNOMODULATING THERAPIES AGAINST TUMORS | Aug 21, 2022 | Pending |
Array
(
[id] => 18496070
[patent_doc_number] => 20230218607
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => ENHANCEMENT OF IMPAIRED MOTOR AND MENTAL FUNCTIONS, USING DEXTROMETHORPHAN AND OXIDASE ENZYME INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 17/891251
[patent_app_country] => US
[patent_app_date] => 2022-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10537
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17891251
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/891251 | ENHANCEMENT OF IMPAIRED MOTOR AND MENTAL FUNCTIONS, USING DEXTROMETHORPHAN AND OXIDASE ENZYME INHIBITOR | Aug 18, 2022 | Abandoned |
Array
(
[id] => 19032391
[patent_doc_number] => 20240082206
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => Composition and Method for Treating Hematologic Cancers
[patent_app_type] => utility
[patent_app_number] => 17/890659
[patent_app_country] => US
[patent_app_date] => 2022-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7561
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17890659
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/890659 | Halogenated xanthene composition and method for treating hematologic cancers | Aug 17, 2022 | Issued |
Array
(
[id] => 20479343
[patent_doc_number] => 12527806
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-20
[patent_title] => Composition for preventing or treating diabetes mellitus
[patent_app_type] => utility
[patent_app_number] => 17/820387
[patent_app_country] => US
[patent_app_date] => 2022-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 1893
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17820387
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/820387 | Composition for preventing or treating diabetes mellitus | Aug 16, 2022 | Issued |